HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

phenylacetate-bisphosphonate

possesses proapoptotic and antangiogenic activities; structure in first source

Also Known As:

PaBp cpd

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Organophosphorus Compounds: 300
  - Organophosphonates: 424
    - Diphosphonates: 11565
      - phenylacetate-bisphosphonate: 1

Experts

1.	Colombo, Bruno M: 1 article (11/2002)
2.	Crépin, Michel: 1 article (11/2002)
3.	Leroux, Yves: 1 article (11/2002)
4.	Martin, Antoine: 1 article (11/2002)
5.	Perret, Gérard Y: 1 article (11/2002)
6.	Salzmann, Jean-Loup: 1 article (11/2002)
7.	Sebbah-Louriki, Malika: 1 article (11/2002)
8.	el Manouni, Driss: 1 article (11/2002)

Related Diseases

1.	Breast Neoplasms (Breast Cancer) 11/01/2002 - "A new phenylacetate-bisphosphonate inhibits breast cancer cell growth by proapoptotic and antiangiogenic effects." 11/01/2002 - "Here we evaluated the antitumor effects of a new bisphosphonate, the phenylacetate-bisphosphonate (PaBp), on human breast cancer MCF7 and MCF7-ras cell lines, both in vitro and in vivo. "

Related Drugs and Biologics

1.	Diphosphonates (Bisphosphonates)